StockVS

Nu Skin Enterprises, Inc. (NUS) Stock Analysis

Consumer Defensive

Nu Skin Enterprises, Inc.

$5.89

$-0.04 (-0.67%)

Last Updated: May 26, 2026

Price History

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Company Overview

Nu Skin Enterprises, Inc. engages in the global development and distribution of beauty and wellness products, offering a portfolio that includes skin care devices, cosmetics, and various personal care items. The company operates within the Consumer Defensive sector and the Household & Personal Products industry, classifications that typically suggest a focus on goods with consistent demand regardless of economic cycles. Nu Skin Enterprises, Inc. maintains a market capitalization of $343.14M and generated annual revenue of $1.49B in the trailing twelve months, employing a workforce of 2800 individuals. These financial figures indicate that while the company possesses a significant operational footprint supported by nearly three thousand employees, its market capitalization suggests a valuation characteristic of smaller-cap entities or those experiencing specific market headwinds relative to its revenue base. The substantial revenue volume combined with a market cap of $343.14M highlights a scenario where the market price per share does not fully reflect the absolute scale of sales, potentially influencing investor perception of the company's current equity value versus its operational earnings power.

Financial Health

The company reported revenue of $1.49B, net income of $160.20M, and EBITDA of $143.14M for the trailing twelve months. The difference between the $1.49B revenue and the $160.20M net income reveals a cost structure where the company retains a significant portion of its top-line sales as profit, yet the gap also reflects the substantial operating expenses required to support a global distribution network and product development. Free cash flow stands at $90.95M, which provides the company with financial flexibility to fund operations, reduce debt, or pursue strategic initiatives without relying solely on external financing. The company holds $241.96M in cash against $308.64M in debt, resulting in a debt-to-equity ratio of 38.33, which indicates a balance sheet that utilizes leverage but maintains a specific capital structure typical for its industry. A current ratio of 2.08 demonstrates strong short-term liquidity, suggesting that the company holds more than twice the assets necessary to cover its immediate liabilities. Return on Equity is 22.0% while Return on Assets is 4.0%, metrics that reveal management is highly effective at generating returns on shareholder capital, though the lower ROA reflects the capital intensity of the assets employed to generate the $1.49B in revenue.

Valuation Assessment

The trailing P/E ratio is 2.24, while the forward P/E is 5.44, implying that the market expects earnings growth that will narrow the gap between current valuations and future price-to-earnings multiples. The price-to-book ratio is 0.43, indicating that the stock trades at a significant discount to its book value, suggesting the market may be pricing in risks or expecting a reversion in asset values. The price-to-sales ratio is 0.23 and the EV/EBITDA is 2.86, alternative valuation metrics that suggest the company is priced very conservatively relative to its sales and earnings generation capabilities. The 52-week high is $14.62 and the 52-week low is $5.32, meaning the current price sits significantly below the recent peak, reflecting a period of consolidation or decline over the past year. The beta value is 1.04, which explains that the stock price volatility is slightly higher than the broader market, moving with a slight premium to the systemic risk of the overall market index.

Growth & Income

Revenue growth is -16.9% year-over-year, while earnings growth is N/A, indicating that the company is currently contracting in terms of top-line sales, a trend that naturally impacts the trajectory of profitability without a specific earnings growth rate available for comparison. The company pays a dividend yield of 3.4% with a payout ratio of 7.6%, a structure that suggests the dividend is highly sustainable given that the payout represents a small fraction of the reported net income. The low payout ratio allows the company to maintain the dividend even if earnings fluctuate, as the payment requires less than 10% of total profits. The overall growth and income profile presents a mixed picture of a mature business generating strong cash flows and dividends but facing significant contraction in revenue during the current period.

Peer Comparison

Nu Skin Enterprises, Inc. (NUS) operates in the Household & Personal Products industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Nu Skin Enterprises, Inc. NUS $287.90M 5.5
The Procter & Gamble Company PG $336.34B 21.1
Unilever PLC UL $123.97B 19.0
Colgate-Palmolive Company CL $71.90B 34.8

The Household & Personal Products industry average P/E ratio is 29.9x. Nu Skin Enterprises, Inc. trades at a P/E of 5.5.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Nu Skin Enterprises, Inc.

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands. The company also provides wellness products, such as ageLOC TRME, LifePak, and Beauty Focus. In addition, it is the research and product development of skin care products, nutritional supplements, and devices. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center and independent marketers. It serves Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, comprising Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, consists of Macau; and Europe & Africa, which includes markets in Europe as well as South Africa. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

Visit website →

Key Statistics

Market Cap
$287.90M
P/E Ratio
5.49
52-Week High
$14.62
52-Week Low
$5.62
Avg Volume
543.17K
Beta
1.02
Dividend Yield
4.05%

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NYSE
Country
United States
Employees
2,800